TriMark Publications

TriMark Publications is a premium market-research and publishing company providing original reports in the biotechnology, medical device, diagnostic and healthcare segments. Clients benefit from an expert, objective source for their research needs, saving time and resources.

TriMark Publications' reports are wide-ranging research publications that explore development activity, recent advances, and emerging trends in health care markets. In addition to our in-house proprietary database, the TriMark staff seeks out experts in the field, conducting extensive secondary research, and develops the findings into a cohesive, well-documented written analysis. Their specialty is constant staff review of reports to continually add and revise so that each report is absolutely up to date.

TriMark Publications
 

List of reports from TriMark Publications

< prev 1    3  4  
Molecular Diagnostics in Infectious Disease Testing
11/1/2013 | published by: TriMark Publications
... molecular diagnostics in infectious disease testing offers one of the most promising areas for growth and innovation. The confluence of breakthroughs in genomics and proteomics--along with the development of microarray devices to measure analytes in ...  |  read more...
$3,400.00
DNA Sequencing and PCR Markets
11/1/2013 | published by: TriMark Publications
... competitive, driven by rapid technological advancements and aggressive price wars. Next-generation sequencing presents an exciting area of growth for life science tool vendors, including those providing sequencers, ancillary instrumentation, reagents and software. This TriMark Publications ...  |  read more...
$3,400.00
Molecular Diagnostics in Genetic Testing
11/1/2013 | published by: TriMark Publications
... microarray devices to measure analytes in the blood and various body tissues are driving significant growth in the segment. Major developments include the integration of specialty labs and gene expression profiling into clinical practice, the ...  |  read more...
$3,400.00
Molecular Diagnostics Markets
11/1/2013 | published by: TriMark Publications
... molecules, the screening and diagnosis of patients, and the optimization of drug therapy. In the past few years, this rapidly evolving field has seen several fascinating developments. This TriMark Publications report describes the specific market ...  |  read more...
$3,400.00
Molecular Diagnostics in Cancer Testing
11/1/2013 | published by: TriMark Publications
... first-generation amplification, DNA probes, fluorescent in-situ hybridization (FISH), second-generation biochips and microfluidics, next-generation signal detection, biosensors and molecular labels, and gene expression profiling using microarrays. These technologies are improving the discovery of therapeutic molecules for ...  |  read more...
$3,400.00
High-Growth Diagnostic Testing Markets
11/1/2013 | published by: TriMark Publications
... clinic and also to lower its costs. Clinical labs experienced a substantial growth during the last decade. The emphasis in this TriMark Publications report is on those companies that are actively developing and marketing high-growth ...  |  read more...
$3,400.00
Drugs of Abuse Testing Markets
11/1/2013 | published by: TriMark Publications
... abuse testing offers promise for significant growth and innovation. Examined in this study are assays for alcohol, cannabinoids, cocaine, amphetamines, opiates and phencyclidine, as well as assays for addictive prescription drugs such as OxyContin. Moreover, ...  |  read more...
$3,400.00
Microscopy Markets
10/1/2013 | published by: TriMark Publications
... emerging Atomic Force Microscopy (AFM) and Raman confocal systems, but traditional techniques will in reality continue to thrive as they contribute to a growing trend toward correlative microscopy in which multiple microscopy and/or spectroscopy techniques ...  |  read more...
$3,400.00
Bioseparation Systems for Global Biopharmaceutical Markets
8/1/2013 | published by: TriMark Publications
... global biomanufacturing capacity. Blockbuster biologics are going off patent, leaving the market open for developing and manufacturing low cost biosimilars. This TriMark Publications report, Bioseparation Systems for Global Biopharmaceutical Markets ,¬†provides market revenue size and ...  |  read more...
$3,400.00
Biologics and Biosimilars World Markets
8/1/2013 | published by: TriMark Publications
... subsequent entry biologics (SEBs), biosimilars are to biologics what generics are to branded drugs; they lower healthcare expenditures. This TriMark Publications report, Biologics and Biosimilars World Markets ,¬†describes the emergence of biologics and biosimilars and ...  |  read more...
$3,400.00
Stem Cell Markets
8/1/2013 | published by: TriMark Publications
... have been classified as either embryonic, adult (tissue-specific or cord blood) stem cells. Recent understanding of stem cell biology may provide new approaches for the treatment of a number of diseases as well as tissue/organ ...  |  read more...
$3,400.00
Companion Biomarkers in Drug Development
8/1/2013 | published by: TriMark Publications
... companion biomarker can be useful in ameliorating the regulatory process for the drug, or acting as an aid to therapeutic use in the clinic. Market opportunities for companion biomarkers are focused in drug development targets, ...  |  read more...
$3,400.00
Microarray Markets
8/1/2013 | published by: TriMark Publications
... microarrays, tissue microarrays, low complexity microarrays and carbohydrate microarrays, are excellent tools for gene expression profiling, biomarker profiling and diagnostics. Pharmaceutical and biotechnology researchers use microarrays to streamline drug target identification, selection, validation and predictive ...  |  read more...
$3,400.00
Point of Care Diagnostic Testing World Markets
7/1/2013 | published by: TriMark Publications
... even days for outside lab results to arrive. Point of care testing covers: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, ...  |  read more...
$3,400.00
Medical Imaging Markets
6/1/2013 | published by: TriMark Publications
... X-ray, ultrasound, computed tomography (CT), positron emission tomography (PET), single photon emission tomography (SPECT), magnetic resonance imaging (MRI), nuclear medicine (NM), mammography and fluoroscopy. Globally, X-ray is the most frequently used imaging procedure with about ...  |  read more...
$3,400.00
Veterinary Health Markets
6/1/2013 | published by: TriMark Publications
... encompassing anti-infectives, parasite controls, reproductive aids, metabolic drugs, feed additives, antibiotics, vaccines, topical solutions and imaging diagnostics as well as novel treatments for chronic conditions such as osteoarthritis, cardiovascular disease and even cancer. This TriMark ...  |  read more...
$3,400.00
Disposable Syringe Markets
6/1/2013 | published by: TriMark Publications
... administer medications. This analysis is intended to provide basic market data pertaining to the U.S. and worldwide market segments. Each market segment is analyzed to determine size, growth rates, sales projections and factors influencing growth ...  |  read more...
$3,400.00
Cancer Diagnostic Testing World Markets
5/1/2013 | published by: TriMark Publications
... million Americans have or have had some form of cancer. Overall costs of the disease are $126 billion annually. Pharmaceutical companies are developing more than 300 new medicines for cancer, some of which are in ...  |  read more...
$3,400.00
Coagulation Diagnostic Testing Markets
4/1/2013 | published by: TriMark Publications
... foreseeable future. Many of the new models of laboratory coagulation testing devices and reagents, which are dominated by prothrombin time (PT) and activated partial thromboplastin time (aPTT), will include upgrades such as greater automation and ...  |  read more...
$3,400.00
Hemoglobin A1c Testing Markets
3/1/2013 | published by: TriMark Publications
... hemoglobin A1c testing is now an essential assay in the diabetes testing repertoire. Its clinical utility and improvements in its accuracy and implementation of standardized protocols have translated into continued market growth. Hemoglobin A1c Testing ...  |  read more...
$3,400.00
Pain Management Treatment Markets
3/1/2013 | published by: TriMark Publications
... segments of the central nervous system (CNS) therapies market. Pain Management Treatment Markets focuses on the role of pain management drugs in clinical use and in drug development for acute pain, chronic pain, neuropathic path ...  |  read more...
$3,400.00
Regenerative Medicine Markets
3/1/2013 | published by: TriMark Publications
... human tissue and organ functions are being made. Whereas before, remedies for damaged tissue or organ functions due to congenital deformities, injuries, diseases or simple wear-and-tear relied upon either the body's ability to repair itself ...  |  read more...
$3,400.00
New Oral Anticoagulants Markets
3/1/2013 | published by: TriMark Publications
... blood and only help prevent the formation of new blood clots. For more than 50 years and until recently, the only oral anticoagulants were vitamin K antagonists such as warfarin. Pradaxa (dabigatran), Xarelto (rivaroxaban), Eliquis ...  |  read more...
$3,400.00
Therapeutic Drug Monitoring Markets
3/1/2013 | published by: TriMark Publications
... drug monitoring testing provides clinical information to optimize dosage regimes and prevent adverse reactions and lack of treatment compliance. Therapeutic Drug Monitoring Markets analyzes the therapeutic drug monitoring market and the various market segments within ...  |  read more...
$3,400.00
Diabetes, Metabolic Syndrome and Cardiovascular Disease
12/1/2012 | published by: TriMark Publications
... juvenile diabetes, now mostly Type 1 diabetes--the obesity crisis linked to the adoption of a high-fat, high-carbohydrate, high-calorie American diet has resulted in skyrocketing rates of diabetes among adults across the world. To compound the ...  |  read more...
$3,400.00
< prev 1    3  4  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!